[시장보고서]국소 약물전달 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측, 제품별, 투여 경로별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

국소 약물전달 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측, 제품별, 투여 경로별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

Topical Drug Delivery Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product, By Route of Administration, By End-User, By Region, & Competition, 2020-2030F

상품코드 : 1748745

리서치사 : TechSci Research

발행일 : 2025년 06월

페이지 정보 : 영문 182 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,500

￦ 6,236,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500

￦ 7,621,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000

￦ 11,086,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

세계의 국소 약물전달 시장 규모는 2024년에 2,443억 5,000만 달러로, 2030년에는 4,051억 달러에 달하며, CAGR 8.75%로 성장할 것으로 예측됩니다.

이러한 성장의 원동력은 비침습적 표적치료에 대한 수요 증가, 특히 노인, 소아, 만성질환자 등 취약계층들에 대한 수요 증가에 기인합니다. 피부나 점막 조직에 직접 적용하는 국소 약물전달은 국소적인 치료 효과와 최소한의 전신 노출로 인해 선호되고 있습니다. 시장 확대는 지질 기반 시스템 및 마이크로니들 패치와 같은 제형 기술 혁신과 간소화된 규제 경로에 의해 더욱 지원되고 있습니다. 또한 건강에 대한 인식이 높아지면서 피부과, 상처 치료, 통증 관리 분야에서 국소 및 경피 제품의 채택이 증가하고 있습니다. 제약회사들이 환자 중심의 외래 환자 친화적인 솔루션으로 전환하는 가운데, 국소 약물전달은 현대 헬스케어 전략에 필수적인 요소로 자리 잡고 있습니다.

시장 개요
예측 기간	2026-2030
시장 규모 : 2024년	2,443억 5,000만 달러
시장 규모 : 2030년	4,051억 달러
CAGR : 2025-2030년	8.75%
급성장 부문	경피 흡수형 제제
최대 시장	북미

시장 성장 촉진요인

피부 질환 및 만성질환의 유병률 증가

주요 시장 이슈

피부 투과성 제한 및 제형의 복잡성

주요 시장 동향

첨단 약물전달 기술 도입 확대

시장 규모·예측
- 금액별
시장 점유율·예측
- 제품별(반고형 제제, 액상 제제, 고형 제제, 경피 흡수형 제제)
- 투여 경로별(경피 약물전달, 안과 약물전달, 직장 약물전달, 경비 약물전달)
- 최종사용자별(병원, 진료소, 재택 헬스케어, 진단 센터, 기타)
- 지역별
- 기업별(2024)
시장 맵

제6장 북미의 국소 약물전달 시장 전망

시장 규모·예측
시장 점유율·예측
북미 : 국가별 분석
- 미국
- 캐나다
- 멕시코

제7장 유럽의 국소 약물전달 시장 전망

시장 규모·예측
시장 점유율·예측
유럽 : 국가별 분석
- 독일
- 영국
- 이탈리아
- 프랑스
- 스페인

제8장 아시아태평양의 국소 약물전달 시장 전망

시장 규모·예측
시장 점유율·예측
아시아태평양 : 국가별 분석
- 중국
- 인도
- 일본
- 한국
- 호주

제9장 남미의 국소 약물전달 시장 전망

시장 규모·예측
시장 점유율·예측
남미 : 국가별 분석
- 브라질
- 아르헨티나
- 콜롬비아

제10장 중동 및 아프리카의 국소 약물전달 시장 전망

시장 규모·예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트

제11장 시장 역학

촉진요인
과제

제12장 시장 동향과 발전

최근 동향
제품 출시
합병과 인수

제13장 세계의 국소 약물전달 시장 : SWOT 분석

제14장 경쟁 구도

Johnson & Johnson Services, Inc.
Nestle SA
GlaxoSmithKline Plc
Novartis AG
Merck & Co. Inc.
Crescita Therapeutics Inc.
Cipla Ltd.
Taro Pharmaceutical Industries Ltd.
Valeant Pharmaceuticals International Inc.
Glenmark Pharmaceuticals Ltd.

제15장 전략적 제안

제16장 조사회사 소개·면책사항

KSA

영문 목차

영문목차

The Global Topical Drug Delivery Market was valued at USD 244.35 Billion in 2024 and is projected to reach USD 405.10 Billion by 2030, growing at a CAGR of 8.75%. This growth is driven by the increasing demand for non-invasive, targeted therapies, especially among vulnerable populations such as the elderly, children, and those with chronic conditions. Topical drug delivery, which involves direct application to the skin or mucosal tissues, is favored for its localized therapeutic effects and minimal systemic exposure. Market expansion is further supported by innovations in formulation technologies like lipid-based systems and microneedle patches, coupled with streamlined regulatory pathways. Additionally, growing health awareness is boosting the adoption of topical and transdermal products in dermatology, wound care, and pain management. As pharmaceutical firms pivot toward more patient-centric and outpatient-friendly solutions, topical drug delivery is becoming an integral part of modern healthcare strategies.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 244.35 Billion
Market Size 2030	USD 405.10 Billion
CAGR 2025-2030	8.75%
Fastest Growing Segment	Transdermal Products
Largest Market	North America

Key Market Drivers

Rising Prevalence of Skin Disorders and Chronic Diseases

Skin disorders are among the most widespread medical conditions globally, impacting individuals of all ages. The growing incidence of issues such as acne, eczema, psoriasis, dermatitis, fungal infections, and rosacea is linked to changing environmental factors, lifestyle habits, genetic predispositions, and heightened diagnosis rates. According to the Global Burden of Disease Study, over 1.9 billion people are affected by skin conditions worldwide, making it a critical public health concern. Chronic skin ailments often require continuous or recurring treatment, with topical formulations offering targeted application and fewer systemic side effects. Acne alone affects approximately 9.4% of the global population and ranks as the eighth most prevalent skin disease. Its high incidence, particularly among adolescents and young adults-where rates can reach 28.3%-creates a robust market opportunity for both over-the-counter and prescription topical treatments. This sustained and growing prevalence ensures consistent demand for topical dermatological products.

Key Market Challenges

Limited Skin Permeability and Formulation Complexity

A key obstacle to market advancement is the restricted permeability of human skin, especially when attempting to deliver drugs with large molecular sizes, hydrophilic properties, or instability. The outermost skin layer, the stratum corneum, serves as a significant barrier to most active pharmaceutical ingredients, particularly biologics, proteins, and peptides. Successfully formulating compounds that can penetrate this layer without compromising safety and efficacy remains a technical challenge. Furthermore, the development of innovative topical delivery systems-such as microneedles, nano-based carriers, or vesicular formulations-demands substantial R&D investment, specialized knowledge, and intricate manufacturing processes. These challenges constrain the variety of drugs suitable for topical delivery and lead to extended product development timelines and increased costs.

Key Market Trends

Growing Adoption of Advanced Drug Delivery Technologies

A prominent trend in the topical drug delivery market is the increased adoption of advanced technologies aimed at enhancing drug stability, skin penetration, and bioavailability. Nanotechnology-enabled systems, including liposomes, niosomes, and solid lipid nanoparticles, are facilitating deeper and more targeted delivery of active ingredients. Additionally, devices like microneedle patches and transdermal systems are opening up new possibilities for administering complex molecules such as peptides and vaccines through the skin. These innovations not only improve treatment outcomes but also extend product lifecycles and enable differentiation in competitive markets. The ability to provide controlled, localized, and sustained drug release is drawing investment and driving robust R&D across the pharmaceutical landscape.

Key Market Players

Johnson & Johnson Services, Inc.
Nestle SA
GlaxoSmithKline Plc
Novartis AG
Merck & Co. Inc.
Crescita Therapeutics Inc.
Cipla Ltd.
Taro Pharmaceutical Industries Ltd.
Valeant Pharmaceuticals International Inc.
Glenmark Pharmaceuticals Ltd

Report Scope:

In this report, the Global Topical Drug Delivery Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Topical Drug Delivery Market, By Product:

Semi-Solid Formulations
Liquid Formulations
Solid Formulations
Transdermal Products

Topical Drug Delivery Market, By Route of Administration:

Dermal Drug Delivery
Ophthalmic Drug Delivery
Rectal Drug Delivery
Nasal Drug Delivery

Topical Drug Delivery Market, By End User:

Hospitals
Clinics
Home Healthcare
Diagnostic Centers
Others

Topical Drug Delivery Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Topical Drug Delivery Market.

Available Customizations:

Global Topical Drug Delivery market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Topical Drug Delivery Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Product (Semi-Solid Formulations, Liquid Formulations, Solid Formulations, Transdermal Products)
- 5.2.2. By Route of Administration (Dermal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, Nasal Drug Delivery)
- 5.2.3. By End-User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Others)
- 5.2.4. By Region
- 5.2.5. By Company (2024)
5.3. Market Map

6. North America Topical Drug Delivery Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Product
- 6.2.2. By Route of Administration
- 6.2.3. By End-User
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Topical Drug Delivery Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Product
    - 6.3.1.2.2. By Route of Administration
    - 6.3.1.2.3. By End-User
- 6.3.2. Canada Topical Drug Delivery Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Product
    - 6.3.2.2.2. By Route of Administration
    - 6.3.2.2.3. By End-User
- 6.3.3. Mexico Topical Drug Delivery Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Product
    - 6.3.3.2.2. By Route of Administration
    - 6.3.3.2.3. By End-User

7. Europe Topical Drug Delivery Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By Route of Administration
- 7.2.3. By End-User
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Topical Drug Delivery Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Product
    - 7.3.1.2.2. By Route of Administration
    - 7.3.1.2.3. By End-User
- 7.3.2. United Kingdom Topical Drug Delivery Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Product
    - 7.3.2.2.2. By Route of Administration
    - 7.3.2.2.3. By End-User
- 7.3.3. Italy Topical Drug Delivery Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Product
    - 7.3.3.2.2. By Route of Administration
    - 7.3.3.2.3. By End-User
- 7.3.4. France Topical Drug Delivery Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Product
    - 7.3.4.2.2. By Route of Administration
    - 7.3.4.2.3. By End-User
- 7.3.5. Spain Topical Drug Delivery Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Product
    - 7.3.5.2.2. By Route of Administration
    - 7.3.5.2.3. By End-User

8. Asia-Pacific Topical Drug Delivery Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Route of Administration
- 8.2.3. By End-User
- 8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Topical Drug Delivery Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Product
    - 8.3.1.2.2. By Route of Administration
    - 8.3.1.2.3. By End-User
- 8.3.2. India Topical Drug Delivery Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Product
    - 8.3.2.2.2. By Route of Administration
    - 8.3.2.2.3. By End-User
- 8.3.3. Japan Topical Drug Delivery Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Product
    - 8.3.3.2.2. By Route of Administration
    - 8.3.3.2.3. By End-User
- 8.3.4. South Korea Topical Drug Delivery Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Product
    - 8.3.4.2.2. By Route of Administration
    - 8.3.4.2.3. By End-User
- 8.3.5. Australia Topical Drug Delivery Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Product
    - 8.3.5.2.2. By Route of Administration
    - 8.3.5.2.3. By End-User

9. South America Topical Drug Delivery Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Route of Administration
- 9.2.3. By End-User
- 9.2.4. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Topical Drug Delivery Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Product
    - 9.3.1.2.2. By Route of Administration
    - 9.3.1.2.3. By End-User
- 9.3.2. Argentina Topical Drug Delivery Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Product
    - 9.3.2.2.2. By Route of Administration
    - 9.3.2.2.3. By End-User
- 9.3.3. Colombia Topical Drug Delivery Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Product
    - 9.3.3.2.2. By Route of Administration
    - 9.3.3.2.3. By End-User

10. Middle East and Africa Topical Drug Delivery Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Product
- 10.2.2. By Route of Administration
- 10.2.3. By End-User
- 10.2.4. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Topical Drug Delivery Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Product
    - 10.3.1.2.2. By Route of Administration
    - 10.3.1.2.3. By End-User
- 10.3.2. Saudi Arabia Topical Drug Delivery Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Product
    - 10.3.2.2.2. By Route of Administration
    - 10.3.2.2.3. By End-User
- 10.3.3. UAE Topical Drug Delivery Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Product
    - 10.3.3.2.2. By Route of Administration
    - 10.3.3.2.3. By End-User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions

13. Global Topical Drug Delivery Market: SWOT Analysis

14. Competitive Landscape

14.1. Johnson & Johnson Services, Inc.
- 14.1.1. Business Overview
- 14.1.2. Product & Service Offerings
- 14.1.3. Recent Developments
- 14.1.4. Financials (If Listed)
- 14.1.5. Key Personnel
- 14.1.6. SWOT Analysis
14.2. Nestle SA
14.3. GlaxoSmithKline Plc
14.4. Novartis AG
14.5. Merck & Co. Inc.
14.6. Crescita Therapeutics Inc.
14.7. Cipla Ltd.
14.8. Taro Pharmaceutical Industries Ltd.
14.9. Valeant Pharmaceuticals International Inc.
14.10.Glenmark Pharmaceuticals Ltd.